Clinical Trial Update: Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating antibody persistence in children previously vaccinated with pneumococcal conjugate vaccine; results completed and posted in 2020…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Due to Streptococcus Pneumoniae
• Streptococcus Pneumoniae Infections

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2020-03-18